SG11201401811WA - Method for preventing and/or treating insulin resistance - Google Patents
Method for preventing and/or treating insulin resistanceInfo
- Publication number
- SG11201401811WA SG11201401811WA SG11201401811WA SG11201401811WA SG11201401811WA SG 11201401811W A SG11201401811W A SG 11201401811WA SG 11201401811W A SG11201401811W A SG 11201401811WA SG 11201401811W A SG11201401811W A SG 11201401811WA SG 11201401811W A SG11201401811W A SG 11201401811WA
- Authority
- SG
- Singapore
- Prior art keywords
- preventing
- insulin resistance
- treating insulin
- treating
- resistance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161528931P | 2011-08-30 | 2011-08-30 | |
| NL2007319 | 2011-08-30 | ||
| PCT/NL2012/050592 WO2013032328A1 (en) | 2011-08-30 | 2012-08-30 | Method for preventing and/or treating insulin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401811WA true SG11201401811WA (en) | 2014-09-26 |
Family
ID=47756609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401811WA SG11201401811WA (en) | 2011-08-30 | 2012-08-30 | Method for preventing and/or treating insulin resistance |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9433650B2 (en) |
| EP (1) | EP2753187B2 (en) |
| JP (1) | JP6116568B2 (en) |
| KR (1) | KR101982491B1 (en) |
| CN (1) | CN104244733B (en) |
| AU (1) | AU2012302364B2 (en) |
| BR (1) | BR112014004890A8 (en) |
| CA (1) | CA2851602C (en) |
| DK (1) | DK2753187T4 (en) |
| PL (1) | PL2753187T3 (en) |
| RU (1) | RU2613322C2 (en) |
| SG (1) | SG11201401811WA (en) |
| WO (1) | WO2013032328A1 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2753187T4 (en) | 2011-08-30 | 2025-10-20 | Caelus Pharmaceuticals B V | Method for preventing and/or treating insulin resistance |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| EP4233545A3 (en) | 2012-11-23 | 2023-10-18 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| HK1218560A1 (en) | 2013-02-04 | 2017-02-24 | Seres Therapeutics, Inc. | Compositions and methods |
| HK1218559A1 (en) | 2013-02-04 | 2017-02-24 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| HK1220326A1 (en) | 2013-03-15 | 2017-05-05 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
| GB2535034A (en) | 2013-07-21 | 2016-08-10 | Whole Biome Inc | Methods and systems for microbiome characterization, monitoring and treatment |
| PT3074027T (en) | 2013-11-25 | 2025-03-20 | Nestle Sa | Synergistic bacterial compositions and methods of production and use thereof |
| EP3082431A4 (en) | 2013-12-16 | 2017-11-15 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| EP4529950A3 (en) * | 2014-10-31 | 2025-08-20 | Pendulum Therapeutics, Inc. | Methods and compositions relating to microbial treatment |
| EP3242957B1 (en) | 2015-01-09 | 2020-03-11 | Wageningen Universiteit | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases |
| RU2737398C1 (en) * | 2015-12-31 | 2020-11-30 | Калус Фармасьютикалс Б.В. | Eubacterium hallii cultivation and preservation method |
| CN106974939B (en) * | 2016-01-15 | 2020-08-25 | 深圳华大生命科学研究院 | Application of Firmicutes probiotics in the treatment and prevention of obesity and related diseases |
| CA3012466A1 (en) | 2016-02-02 | 2017-08-10 | Oncoimmune, Inc. | Use of cd24 proteins for treating leptin-deficient conditions |
| CN108697742A (en) * | 2016-02-25 | 2018-10-23 | 卡勒斯制药有限公司 | Composition for preventing and/or treating vitamin B12 deficiency disease and method |
| US11202807B2 (en) | 2016-04-11 | 2021-12-21 | Wageningen Universiteit | Bacterial species |
| EP3509575B1 (en) | 2016-09-07 | 2025-03-19 | Temple University Of The Commonwealth System Of Higher Education | Compositions and methods for treatment of insulin resistance |
| CA3049299A1 (en) * | 2017-01-19 | 2018-07-26 | Pleonova Ab | Autologous fecal sample for use in the treatment of microbial dysbiosis |
| US11701394B2 (en) | 2017-08-14 | 2023-07-18 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| AU2018326705A1 (en) | 2017-08-30 | 2020-03-05 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
| KR20200079292A (en) | 2017-10-30 | 2020-07-02 | 세레스 테라퓨틱스, 인코포레이티드 | Compositions and methods for treating antibiotic resistance |
| BR112020016771A2 (en) * | 2018-03-02 | 2020-12-15 | Academisch Medisch Centrum | FECAL MATTER FOR USE IN THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE. |
| EP3823651A4 (en) | 2018-07-19 | 2022-04-27 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MICROBIAL GRAFT |
| EP3870691A4 (en) | 2018-09-13 | 2022-09-07 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| KR20220003539A (en) | 2019-04-09 | 2022-01-10 | 덤바이온트, 인코포레이티드 | Compositions and methods for improving skin health and for treating and preventing diseases, disorders and conditions associated with pathogenic microbes |
| NL2024569B1 (en) | 2019-12-24 | 2021-09-06 | Univ Wageningen | Bacterium comprising myo-inositol to propionate pathway |
| JP2022544369A (en) | 2019-08-14 | 2022-10-18 | ヴァーヘニンゲン・ウニヴェルシテイト | Bacteria containing the myo-inositol-propionate pathway |
| RU2734336C1 (en) * | 2020-03-27 | 2020-10-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for early non-invasive diagnosis of metabolic disorders in children and adolescents |
| TW202206062A (en) | 2020-04-24 | 2022-02-16 | 美國坦普大學 高等教育聯邦系統 | Methods for treatment of non-alcoholic steatohepatitis |
| US20240269198A1 (en) * | 2020-10-14 | 2024-08-15 | Dermbiont, Inc. | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes |
| CN113604400B (en) * | 2021-08-26 | 2023-06-02 | 王玉莹 | Novel lactobacillus YUYINGW with diabetes preventing or treating effect |
| NL2036594B1 (en) | 2023-12-20 | 2025-07-04 | Univ Wageningen | Bacterium comprising phytate-degradation pathway |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| CZ81997A3 (en) * | 1996-03-20 | 1997-10-15 | Immuno Ag | Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use |
| US5902578A (en) * | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
| US6227863B1 (en) | 1998-02-18 | 2001-05-08 | Donald Spector | Phonics training computer system for teaching spelling and reading |
| US6224863B1 (en) * | 1998-10-30 | 2001-05-01 | University Of South Carolina | Antibiotic composition from alcaligenes species and method for making and using the same |
| EP1228769A1 (en) * | 2001-02-02 | 2002-08-07 | Jörg-Peter Prof. Schür | Symbiotic regenerative composition |
| JP4307006B2 (en) * | 2002-03-28 | 2009-08-05 | キリンフードテック株式会社 | Diabetes preventive |
| CA2492805C (en) † | 2002-07-18 | 2015-05-12 | Agricultural Research Council | Megasphaera elsdenii strain and its uses |
| GB0307026D0 (en) | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
| KR101357015B1 (en) † | 2004-12-22 | 2014-02-03 | 더 미시간 바이오테크노로지 인스티튜트 | Recombinant microorganisms for increased production of organic acids |
| US20080069861A1 (en) * | 2006-09-19 | 2008-03-20 | National Starch And Chemical Investment Holding Corporation | Probiotic/Non-Probiotic Combinations |
| EP2102350A4 (en) † | 2006-12-18 | 2012-08-08 | Univ St Louis | INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER |
| JP5350626B2 (en) * | 2007-12-20 | 2013-11-27 | キリンフードテック株式会社 | Dendritic cell activation composition |
| US20110189149A1 (en) † | 2008-06-20 | 2011-08-04 | Remy Burcelin | New Uses of Lactic Acid Bacteria and Bifidobacteria |
| US9603876B2 (en) * | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| BRPI1007312A2 (en) * | 2009-01-23 | 2020-08-18 | Kadant Inc. | systems and methods for providing improved dehydration performance in a papermaking machine. |
| US20120027737A1 (en) † | 2009-03-25 | 2012-02-02 | Chr-Hansen A/S | Use of probiotics to ameliorate diet-induced insulin resistance |
| WO2011043654A1 (en) | 2009-10-05 | 2011-04-14 | Aak Patent B.V. | Methods for diagnosing irritable bowel syndrome |
| AU2011256017B2 (en) * | 2010-05-18 | 2013-11-28 | Able Corporation | Method for inhibition of methane production |
| WO2012142605A1 (en) | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
| DK2753187T4 (en) | 2011-08-30 | 2025-10-20 | Caelus Pharmaceuticals B V | Method for preventing and/or treating insulin resistance |
| RU2737398C1 (en) † | 2015-12-31 | 2020-11-30 | Калус Фармасьютикалс Б.В. | Eubacterium hallii cultivation and preservation method |
-
2012
- 2012-08-30 DK DK12758652.7T patent/DK2753187T4/en active
- 2012-08-30 CA CA2851602A patent/CA2851602C/en active Active
- 2012-08-30 US US14/241,851 patent/US9433650B2/en active Active
- 2012-08-30 RU RU2014112223A patent/RU2613322C2/en active
- 2012-08-30 JP JP2014528318A patent/JP6116568B2/en active Active
- 2012-08-30 SG SG11201401811WA patent/SG11201401811WA/en unknown
- 2012-08-30 CN CN201280053708.2A patent/CN104244733B/en active Active
- 2012-08-30 EP EP12758652.7A patent/EP2753187B2/en active Active
- 2012-08-30 PL PL12758652T patent/PL2753187T3/en unknown
- 2012-08-30 KR KR1020147008451A patent/KR101982491B1/en active Active
- 2012-08-30 WO PCT/NL2012/050592 patent/WO2013032328A1/en not_active Ceased
- 2012-08-30 AU AU2012302364A patent/AU2012302364B2/en active Active
- 2012-08-30 BR BR112014004890A patent/BR112014004890A8/en not_active Application Discontinuation
-
2016
- 2016-07-11 US US15/207,335 patent/US9623055B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160317589A1 (en) | 2016-11-03 |
| JP2014527068A (en) | 2014-10-09 |
| EP2753187B2 (en) | 2025-08-06 |
| BR112014004890A8 (en) | 2018-02-06 |
| CN104244733A (en) | 2014-12-24 |
| US9433650B2 (en) | 2016-09-06 |
| DK2753187T4 (en) | 2025-10-20 |
| CN104244733B (en) | 2017-07-28 |
| EP2753187A1 (en) | 2014-07-16 |
| RU2014112223A (en) | 2015-10-10 |
| KR20140128936A (en) | 2014-11-06 |
| AU2012302364B2 (en) | 2016-07-28 |
| PL2753187T3 (en) | 2019-05-31 |
| EP2753187B1 (en) | 2018-10-24 |
| JP6116568B2 (en) | 2017-04-19 |
| RU2613322C2 (en) | 2017-03-15 |
| BR112014004890A2 (en) | 2017-03-21 |
| US20140294774A1 (en) | 2014-10-02 |
| DK2753187T3 (en) | 2019-01-28 |
| KR101982491B1 (en) | 2019-05-27 |
| WO2013032328A1 (en) | 2013-03-07 |
| CA2851602C (en) | 2020-07-14 |
| CA2851602A1 (en) | 2013-03-07 |
| AU2012302364A1 (en) | 2014-04-17 |
| US9623055B2 (en) | 2017-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401811WA (en) | Method for preventing and/or treating insulin resistance | |
| EP2890391A4 (en) | Method and composition for treating hyperglycemia | |
| EP2804646A4 (en) | Multiple dose syringe and method | |
| PL2696754T3 (en) | Stress-measuring device and method | |
| EP2615533A4 (en) | Interaction method and interaction device | |
| PT2252312E (en) | Methods for preventing or treating insulin resistance | |
| IL234700A0 (en) | Composition for preventing and/or treating dermatosis and method for obtaining same | |
| GB201122195D0 (en) | Composition and method | |
| GB2494420B (en) | Rotary control and method | |
| PT2663864T (en) | Immunodiversity assessment method and its use | |
| GB201408236D0 (en) | Composition and method | |
| EP2755363A4 (en) | Data-fast-distribution method and device | |
| EP2698762A4 (en) | Eyelid-detection device, eyelid-detection method, and program | |
| IL220594A0 (en) | Treatment method | |
| GB201101862D0 (en) | Method and device | |
| SG11201400204VA (en) | Fish anesthetic and method | |
| GB201106433D0 (en) | Composition and method | |
| EP2914515A4 (en) | Warehouse-related method and facility | |
| PL2684100T3 (en) | Impregnating method and impregnating device | |
| ZA201502205B (en) | Ectoparasitic treatment method and composition | |
| IL229438A0 (en) | Methods for treating obesity and/or metabolic syndrome | |
| GB201222820D0 (en) | Woolscouring method and composition | |
| GB201120703D0 (en) | Heat-treatment method and apparatus | |
| GB201105523D0 (en) | Treatment method | |
| IL238331A0 (en) | Method for treating type 1 and type ii diabetes |